On October 13, WUXI APPTEC fell 3.56% in regular trading, trading at HK$200.4 with Turnover of HK$186 million. The stock faced pressure as the broader pharmaceutical outsourcing and life sciences tools sector weakened, triggering a sector-wide pullback effect.
Earlier, strong interim results, full conversion of convertible bonds, and concentrated institutional buying drove the stock to a record high of HK$219.2 on October 7. The sharp run-up has created significant short-term profit-taking pressure, which, combined with sector-wide selling, led to the current decline.
Wuxi AppTec Co., Ltd. is a China-based company primarily engaged in new drug research, development, and manufacturing services.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)